Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Minnesota Oncology - Maple Grove

Maple Grove, Minnesota 55369, United StatesNot linked to an institution yet

21running trials

The trials here

What the 21 trials at this site are about, from their registry records.

Conditions: Colorectal cancer5 trials
Lung cancer5 trials
Ovarian cancer4 trials
Gastric and oesophageal cancer3 trials
Multiple myeloma3 trials
Bladder cancer2 trials
Prostate cancer2 trials
Acute lymphoblastic leukaemia1 trial
Acute myeloid leukaemia1 trial
Childhood cancers1 trial
Chronic lymphocytic leukaemia1 trial
Chronic myeloid leukaemia1 trial
and 7 more
Phase: Phase 310 trials
Phase 23 trials
Phase 2/32 trials
Status: Recruiting19 trials
Active, not recruiting2 trials
Lead sponsor: NRG Oncology7 trials
Alliance for Clinical Trials in Oncology6 trials
ECOG-ACRIN Cancer Research Group6 trials
National Cancer Institute (NCI)1 trial
SWOG Cancer Research Network1 trial

Running trials

Recruiting
Family Communications After Genetic Testing
NCT07143487· Alliance for Clinical Trials in Oncology· Source
Contact: Yan Ji (principal investigator)
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NCT07283939· Alliance for Clinical Trials in Oncology· Source
Contact: Margaret B. Nolan (principal investigator)
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NCT07097142· Phase 3· NRG Oncology· Source
Contact: Charles Shideman (principal investigator)
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06580314· Phase 3· NRG Oncology· Source
Contact: Jessica A. Thomes Pepin (principal investigator)
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
NCT06475989· Phase 3· ECOG-ACRIN Cancer Research Group· Source
Contact: David M. King (principal investigator)
Active, not recruiting
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
NCT06632327· Phase 3· Alliance for Clinical Trials in Oncology· Source
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
NCT06295367· ECOG-ACRIN Cancer Research Group· Source
Contact: Margaret B. Nolan (principal investigator)
Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05879926· Phase 3· NRG Oncology· Source
Contact: Joleen M. Hubbard (principal investigator)
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
NCT05677490· Phase 3· Alliance for Clinical Trials in Oncology· Source
Contact: Yan Ji (principal investigator)
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069· Alliance for Clinical Trials in Oncology· Source
Contact: Yan Ji (principal investigator)
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
NCT05174169· Phase 2/3· NRG Oncology· Source
Contact: Joleen M. Hubbard (principal investigator)
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NCT05080673· NRG Oncology· Source
Contact: Yan Ji (principal investigator)
Active, not recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
NCT04804644· Phase 3· NRG Oncology· Source
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
NCT04566328· Phase 3· ECOG-ACRIN Cancer Research Group· Source
Contact: David M. King (principal investigator)
Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
NCT04423211· Phase 3· ECOG-ACRIN Cancer Research Group· Source
Contact: David M. King (principal investigator)
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT04251052· NRG Oncology· Source
Contact: Jessica A. Thomes Pepin (principal investigator)
Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
NCT03937635· Phase 3· ECOG-ACRIN Cancer Research Group· Source
Contact: David M. King (principal investigator)
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445· Phase 2/3· SWOG Cancer Research Network· Source
Contact: David M. King (principal investigator)
Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
NCT03191149· Phase 2· National Cancer Institute (NCI)· Source
Contact: David M. King (principal investigator)
Recruiting
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537· Phase 2· ECOG-ACRIN Cancer Research Group· Source
Contact: David M. King (principal investigator)
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
NCT02523014· Phase 2· Alliance for Clinical Trials in Oncology· Source
Contact: Yan Ji (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Colorectal cancer5 recruiting
Ovarian cancer4 recruiting
Gastric and oesophageal cancer3 recruiting
Lung cancer3 recruiting
Multiple myeloma3 recruiting
Bladder cancer2 recruiting
Prostate cancer2 recruiting
Acute lymphoblastic leukaemia1 recruiting
Acute myeloid leukaemia1 recruiting
Childhood cancers1 recruiting
Chronic lymphocytic leukaemia1 recruiting
Chronic myeloid leukaemia1 recruiting
Head and neck cancer1 recruiting
Kidney cancer1 recruiting
Melanoma1 recruiting
Meningioma1 recruiting
Metastatic breast cancer1 recruiting
Pancreatic cancer1 recruiting
Thyroid cancer1 recruiting

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error